Tipranavir (TPV) Genotypic Inhibitory Quotient Predicts Virological Response at 48 Weeks to TPV-Based Salvage Regimens

The virological response (VR) to a tipranavir-ritonavir (TPV-RTV)-based regimen had been shown to be associated with a number of mutations in the protease gene, the use of enfuvirtide (T20), and the TPV phenotypic inhibitory quotient (IQ). The role of the TPV genotypic IQ (gIQ) has not yet been full...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: de Requena, Daniel Gonzalez, Bonora, Stefano, Calcagno, Andrea, D'Avolio, Antonio, Siccardi, Marco, Fontana, Silvia, Milia, Maria Grazia, Sciandra, Mauro, Garazzino, Silvia, Di Garbo, Antonio, Baietto, Lorena, Trentini, Laura, Di Perri, Giovanni
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology (ASM) 2008
Konular:
Antiviral Agents
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2258544/
https://ncbi.nlm.nih.gov/pubmed/18160524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01063-07
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller